Latest News
- IR Summary of Consolidated Financial Results for the Nine Months Ended September 30, 2020 (J-GAAP)
- IR Announcement of the starting of the supply of the cell cultureware to the company, developing the cells for research of the infectious disease
- IR Fiscal 2020 First-Half Earnings Results Presentation
- IR Summary of Consolidated Financial Results for the Six Months Ended June 30, 2020 (J-GAAP)
- IR Summary of Consolidated Financial Results for the Three Months Ended March 31, 2020 (J-GAAP)
- IR Fiscal 2019 Earnings Results Presentation
- IR Mid-term Business Plan Fiscal Year 2020 to Fiscal Year 2022
- IR Summary of Consolidated Financial Results for the Year Ended December 31, 2019